Cargando…

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate - A Case Report -

Transient osteoporosis of the hip (TOH) is a rare disorder of unknown etiology that is characterized by acute onset of disabling bone pain. The locally increased bone turnover and low bone mineral density (BMD) associated with this disorder indicate a potential role for an antiresorptive agent such...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seok, Hyun, Kim, Yun Tae, Kim, Sang Hyun, Cha, Jang Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Academy of Rehabilitation Medicine 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309219/ https://www.ncbi.nlm.nih.gov/pubmed/22506155 http://dx.doi.org/10.5535/arm.2011.35.3.432

Ejemplares similares

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
por: Agarwala, Sanjay, et al.
Publicado: (2019)

Transient osteoporosis of the hip
por: McWalter, Patricia, et al.
Publicado: (2009)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Transient Osteoporosis of the Hip: A Case Report
por: Pande, K, et al.
Publicado: (2017)

Transient Osteoporosis of the Hip: A Case Report
por: Ciftci, Selda, et al.
Publicado: (2020)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009)

Intravenous Zoledronate for a Patient with Paget's Disease
por: Kim, Ki-Choul
Publicado: (2014)

Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
por: Al-Bogami, Mohammed M., et al.
Publicado: (2015)

Transient osteoporosis of the hip
por: Thomas, Joe, et al.
Publicado: (2019)

Transient Migratory Osteoporosis of the Hip and Talus: A Case Report
por: Vaishya, Raju, et al.
Publicado: (2017)

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
por: Al Elq, Abdulmohsen H.
Publicado: (2013)

Transient osteoporosis of the hip after bariatric surgery
por: Hong, Cierra S., et al.
Publicado: (2018)

Transient osteoporosis: Not just the hip to worry about
por: Berman, Nicola, et al.
Publicado: (2016)

Transient osteoporosis of the hip: Physicians the occupation of at risk
por: Fattah, Abolfazl, et al.
Publicado: (2021)

Neridronate for transient osteoporosis of the hip in a child
por: Gaggiano, C., et al.
Publicado: (2022)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
por: Gazoni, Fernanda Martins, et al.
Publicado: (2023)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011)

Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010)

Simultaneous Bilateral Transient Osteoporosis of the Hip without Pregnancy
por: Okada, Yasuaki, et al.
Publicado: (2016)

SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis
por: Pyone, Zar Chi, et al.
Publicado: (2020)

Intravenous Zoledronate 4 mg for the treatment of post-menopausal osteoporosis: A prospective open-labeled study
por: Arunthanachaikul, Thunyawarin, et al.
Publicado: (2021)

CT Evidence for Subchondral Trabecular Injury of the Femoral Head in Transient Osteoporosis of the Hip: A Case Report
por: Kim, Yong Lae, et al.
Publicado: (2010)

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
por: Kong, Sung Hye, et al.
Publicado: (2022)

Transient Osteoporosis of the Hip: Risk and Therapy
por: Bashaireh, Khaldoon M, et al.
Publicado: (2020)

Zoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case report
por: Evangelatos, Gerasimos, et al.
Publicado: (2021)

Clinical effect of Zoledronic Acid in the treatment of Senile Osteoporosis
por: Kong, Li, et al.
Publicado: (2020)

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
por: Lu, Yanhui, et al.
Publicado: (2013)

THU442 A Case Of Early Medication Related Osteonecrosis Of The Jaw In Patient Receiving Intravenous Zoledronate For Treatment Of Osteoporosis
por: Ekpe, Victor, et al.
Publicado: (2023)

Migrating transient osteoporosis of the hip in a 30-year-old man
por: Suresh, SS, et al.
Publicado: (2009)

Transient osteoporosis of the hip and subclinical hypothyroidism: an unusual dangerous duet? Case report and pathogenetic hypothesis
por: Paoletta, Marco, et al.
Publicado: (2020)

Effect of Zoledronic Acid on Acro-Osteolysis and Osteoporosis in a Patient with Hajdu-Cheney Syndrome
por: Hwang, Sena, et al.
Publicado: (2011)

Transient Osteoporosis of the Hip: A Radiologist’s Perspective
por: Khan, Muhammad Mehraiz, et al.
Publicado: (2022)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women
por: Chao, Ma, et al.
Publicado: (2013)

Transient osteoporosis of the hip with a femoral neck fracture during follow-up: a case report
por: Tabata, Yusuke, et al.
Publicado: (2022)

Investigation of Intravenous Zoledronic Acid Therapy on Circulating Lymphocyte Subpopulation in Patients with Primary Osteoporosis: A Pilot Study
por: Cui, Min, et al.
Publicado: (2021)

Call to action: a five nations consensus on the use of intravenous zoledronate after hip fracture
por: Johansen, Antony, et al.
Publicado: (2023)

Transient Osteoporosis of the Hip: A Mysterious Cause of Hip Pain in Adults
por: Vaishya, Raju, et al.
Publicado: (2017)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
por: Ringe, Johann D
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rl9ksrhes3diiu1vuieb3aqofb